Somatostatin receptor-targeted organometallic iridium(III) complexes as novel theranostic agents
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081707%3A_____%2F17%3A00476264" target="_blank" >RIV/68081707:_____/17:00476264 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1039/c7cc01946g" target="_blank" >http://dx.doi.org/10.1039/c7cc01946g</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1039/c7cc01946g" target="_blank" >10.1039/c7cc01946g</a>
Alternative languages
Result language
angličtina
Original language name
Somatostatin receptor-targeted organometallic iridium(III) complexes as novel theranostic agents
Original language description
A novel somatostatin receptor-targeted anticancer agent based on the conjugation of a highly cytotoxic and luminescent cyclometalated iridium(III) complex to tumor-targeting vectors based on octreotide peptide has been described, and its potential for targeted theranostic applications has been demonstrated.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Chemical Communications
ISSN
1359-7345
e-ISSN
—
Volume of the periodical
53
Issue of the periodical within the volume
40
Country of publishing house
GB - UNITED KINGDOM
Number of pages
4
Pages from-to
5523-5526
UT code for WoS article
000401602900009
EID of the result in the Scopus database
—